Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Impact of Pain Assessment on the Hospital Length of Stay of Patients in a Rehabilitation Unit

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02913833
Recruitment Status : Completed
First Posted : September 26, 2016
Last Update Posted : January 23, 2018
Sponsor:
Information provided by (Responsible Party):
Samar Hatem, Brugmann University Hospital

Brief Summary:

The financing of the Belgian hospitals is based on a system taking into account the length of hospitalization of a given patient according to his/her pathology, his/her age and his/her geriatric characteristics. This system encourages all hospital to lower the hospitalization duration to the national average for these criteria. This results in better efficiency in the management of hospitalizations but also means a swifter transfer to structures exempted from this system such as revalidation units, nursing homes and psychiatric units. An assessment of the differences in the medical practice, in terms of quality and outcomes of care, is essential for any reform willing to reduce medical costs.

Pain management is part of the quality indicators within hospitals. Pain is defined by the International Association for the Study of Pain as "an unpleasant sensory and emotional experience, associated to present or potential tissue damage, or described in terms of such a damage". Several studies have showed that pain affects the quality of life and impacts the daily activities. Acute or chronic pain can cause adverse symptoms such as sleep disturbance, appetite loss, decreased concentration, mood changes and the disruption of familial, work and social activities. Pain might also slow down revalidation processes. A study performed by Aprile et al showed that pain negatively influenced the rehabilitation program of a quarter of the patients having had a stroke. The functional recovery was slower and the costs were higher.

The aim of this study is to determine if the systematic evaluation of the pain of a patient hospitalized in a revalidation unit has an impact on his/her length of stay.


Condition or disease Intervention/treatment Phase
Pain Other: Pain evaluation Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 180 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: The Impact of Pain Assessment on the Hospital Length of Stay of Patients in a Rehabilitation Unit
Actual Study Start Date : March 9, 2016
Actual Primary Completion Date : December 12, 2017
Actual Study Completion Date : December 12, 2017

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Daily pain evaluation
Patients recruited in a sequential order within the chronic revalidation unit of the CHU Brugmann hospital, Queen Astrid site.
Other: Pain evaluation
Pain will be assessed four times per day on a visual analogic scale.

No Intervention: Control
Patients recruited in a sequential order within the chronic revalidation unit of the CHU Brugmann hospital, Queen Astrid site.



Primary Outcome Measures :
  1. Pain score (EVA) [ Time Frame: 5 minutes, 4 times per day ]
    Pain assessment on the Visual Analogic Scale (EVA)

  2. Hospitalization duration [ Time Frame: Hospitalization length (average of 48 days) ]
  3. HADS score [ Time Frame: Baseline (first day of hospitalisation) ]
    Hospital Anxiety Depression Scale (questionnaire)

  4. HADS score [ Time Frame: Day 30 of hospitalisation ]
    Hospital Anxiety Depression Scale (questionnaire)

  5. Barthel Index [ Time Frame: Baseline (first day of hospitalisation) ]
    Daily life activities assessment

  6. Barthel Index [ Time Frame: Day 30 of hospitalisation ]
    Daily life activities assessment

  7. CACS score [ Time Frame: Hospitalization length (average of 48 days) ]
    Composite score of analgesics consumption



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Sequential inclusion of all patients hospitalized in the chronic revalidation hospital unit of the CHU Brugmann - Queen Astrid site

Exclusion Criteria:

  • Pathological cognitive state (MMS<23/30)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02913833


Locations
Layout table for location information
Belgium
CHU Brugmann
Brussels, Belgium, 1020
Sponsors and Collaborators
Brugmann University Hospital
Publications:
Layout table for additonal information
Responsible Party: Samar Hatem, Head of clinic, Brugmann University Hospital
ClinicalTrials.gov Identifier: NCT02913833    
Other Study ID Numbers: CHUB- EVA-REVA
First Posted: September 26, 2016    Key Record Dates
Last Update Posted: January 23, 2018
Last Verified: January 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Samar Hatem, Brugmann University Hospital:
Pain
Hospital length of stay
Revalidation unit